Parnaparin is an antithrombotic agent used to prevent and treat deep vein thrombosis (DVT) and other thromboembolic disorders. DVT occurs when blood clots form in deep veins, often in the legs. Parnaparin works by inhibiting factor Xa, a key component in the coagulation cascade, thereby preventing clot formation. Its clinical relevance is significant in reducing the risk of thromboembolic complications. In summary, Parnaparin is crucial for managing and preventing blood clots.
Parnaparin inhibits factor Xa and thrombin, preventing the conversion of fibrinogen to fibrin, thereby reducing clot formation.
No published brands for this salt yet.